510(k) device
RFID Localization System
Health Beacons, Inc. · Marker, Radiographic, Implantable (NEU, Class II) · First FDA decision Sep 13, 2019, newest May 6, 2020Breast cancer
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
4
Naming "RFID Localization"
MAUDE reports
0
Brand "RFID Localization", since 2015
PubMed studies
12
Mentioning "RFID Localization"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing RFID Localization System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- RFID Localization System510(k)
K193189 · Decided May 6, 2020 · 169 days after receipt
Device type: Marker, Radiographic, Implantable (NEU) · General & Plastic Surgery
- RFID Localization System510(k)
K190932 · Decided Sep 13, 2019 · 156 days after receipt
Device type: Marker, Radiographic, Implantable (NEU) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "RFID Localization", any status and sponsor, newest update first.
Centre Jean PerrinAcademic, hospital or other
NCT04750889 · 80 participants · Start May 15, 2021 · Primary completion Apr 24, 2023
Device: RFID tags; Wire localization · For: Breast Neoplasm Female
Sites: Clermont-Ferrand, France
University of Missouri-ColumbiaAcademic, hospital or other
NCT03684408 · 38 participants · Start Oct 18, 2018 · Primary completion Apr 19, 2021
Device: RFID Localization; Wire Localization and 1 more · For: Breast Tumor
Sites: Columbia, Missouri
Jonsson Comprehensive Cancer CenterAcademic, hospital or other
NCT03202472 · 50 participants · Start Aug 3, 2017 · Primary completion Jan 12, 2018
Device: Implanted Medical Device · For: Breast Neoplasm; Lesion
Sites: Los Angeles, California
1 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "RFID Localization", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NEU
1,678 reports: 518 malfunction, 1,149 injury, 1 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "RFID Localization"[tiab]. The summary above synthesizes these.
- A passive RFID-based location system for personnel and asset monitoring.
Hsiao RS, Kao CH, Chen TX, et al. · Technol Health Care · 2018
- RFID trial: localization of non-palpable breast lesions using radiofrequency identification tags or wire.
Veyssiere H, Dressaire M, Pete R, et al. · BMC Cancer · 2023Equivalence Trial
- Efficacy of the Radiofrequency Identification Technique in Breast Cancer Patients: A Single Institution Retrospective Study.
Kassem M, Kamr A, Wright CB, et al. · Eur J Breast Health · 2024
- ANTspin: Efficient Absolute Localization Method of RFID Tags via Spinning Antenna.
Shen L, Zhang Q, Pang J, et al. · Sensors (Basel) · 2019
- Matching Detection of Crane Hook and Ladle Lug before Ladle Hoisting.
Lyu J, Shi R, Yang Y, et al. · Sensors (Basel) · 2019
- Radiofrequency localization of nonpalpable breast cancer in a multicentre prospective cohort study: feasibility, clinical acceptability, and safety.
Christenhusz A, den Dekker BM, van Dalen T, et al. · Breast Cancer Res Treat · 2023Multicenter Study
- Radiofrequency identification tag localization of nonpalpable breast lesions: a systematic review and meta-analysis.
Daly GR, Alabdulrahman M, Dowling GP, et al. · Eur Radiol Exp · 2025Meta-Analysis, Systematic Review
- Performance, Accuracy and Generalization Capability of RFID Tags' Constellation for Indoor Localization.
Hatem E, Abou-Chakra S, Colin E, et al. · Sensors (Basel) · 2020
- Localization and Tracking of an Indoor Autonomous Vehicle Based on the Phase Difference of Passive UHF RFID Signals.
Zhang Y, Gong X, Liu K, et al. · Sensors (Basel) · 2021
- A Passive Localization Algorithm That Integrates RSSI and PDOA Location Observations in a Mixed Scene.
Li G, Chen M, Zhang H, et al. · Sensors (Basel) · 2026
- A multicenter prospective cohort study to evaluate feasibility of radio-frequency identification surgical guidance for nonpalpable breast lesions: design and rationale of the RFID Localizer 1 Trial.
den Dekker BM, Christenhusz A, van Dalen T, et al. · BMC Cancer · 2022Multicenter Study
- Bracketed Lumpectomy: A Comparison of Radiofrequency Identification Tag Localization to Wire Localization.
Garcia DI, Daly AE, Anderman KJ, et al. · Ann Surg Oncol · 2026Comparative Study
Other devices of this type
Also filed under product code NEU.
- HydroMARK Breast Biopsy Site MarkerDevicor Medical Products, Inc. · 510(k) 2022
- MOLLI 2 SystemMolli Surgical, Inc. · 510(k) 2024
- HydroMARK Plus Breast Biopsy Site Marker (Dragonfly Shape)Devicor Medical Products, Inc. · 510(k) 2026
- UltraCor Twirl Breast Tissue MarkerBard Peripheral Vascular, Inc. · 510(k) 2025
- Cianna Medical SAVI Scout Reflector and SAVI Scout SystemCianna Medical, Inc. · 510(k) 2018
- Beacon Tissue Marker (SE)Scion Medical Technologies, LLC · 510(k) 2015
- Biopsy Sciences, Inc. Hydromark Brest Biosy Site MarkerBiopsy Sciences, LLC · 510(k) 2012
- Securmark Biopsy Site Marking SystemSuros Surgical Systems, Inc. A Hologic Company · 510(k) 2010
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.